Cumberland Pharmaceuticals (CPIX) Change in Intangibles (2010 - 2026)

Cumberland Pharmaceuticals' (CPIX) quarterly Change in Intangibles came in at $19155.0 in Q1 2026, up 5.25% year-on-year from $18199.0 in Q1 2025, and down 56.31% quarter-over-quarter from $43842.0 in Q4 2025.

Cumberland Pharmaceuticals (CPIX) Change in Intangibles (2010 - 2026) Analysis & Trends

Cumberland Pharmaceuticals has disclosed Change in Intangibles across 17 years of filings, most recently posting $19155.0 for Q1 2026.

  • Change in Intangibles for Q1 2026 came in at $19155.0, up 5.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $85358.0 (down 25.7% YoY), and the FY2025 annual result was $84402.0, down 25.47% from the prior year.
  • Change in Intangibles came in at $19155.0 for Q1 2026 at Cumberland Pharmaceuticals, down from $43842.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $1.8 million in Q4 2022 to a low of $8449.0 in Q3 2025.
  • The 5-year median for Change in Intangibles is $32536.0 (2024), against an average of $138838.5.
  • Across the five-year window, Change in Intangibles jumped 2451.73% in 2022 and slumped 97.88% in 2023, its largest moves.
  • Cumberland Pharmaceuticals' Change in Intangibles stood at $1.8 million in 2022, then plunged by 97.88% to $38044.0 in 2023, then plunged by 35.53% to $24526.0 in 2024, then surged by 78.76% to $43842.0 in 2025, then sank by 56.31% to $19155.0 in 2026.
  • The last three Change in Intangibles figures came in at $19155.0 (Q1 2026), $43842.0 (Q4 2025), and $8449.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn -
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn -
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn -
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn -
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn -
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn -
10 Cumberland Pharmaceuticals 84.67 Mn 73.33 Mn 7.20 Mn 19,155.00

Historic Data

Download Data
DateValue
Mar 31, 2026 19,155.00
Mar 31, 2026 19,155.00
Dec 31, 2025 43,842.00
Dec 31, 2025 43,842.00
Sep 30, 2025 8,449.00
Sep 30, 2025 8,449.00
Jun 30, 2025 13,912.00
Jun 30, 2025 13,912.00
Mar 31, 2025 18,199.00
Mar 31, 2025 18,199.00
Dec 31, 2024 24,526.00
Dec 31, 2024 24,526.00
Sep 30, 2024 32,536.00
Sep 30, 2024 32,536.00
Jun 30, 2024 39,626.00
Jun 30, 2024 39,626.00
Mar 31, 2024 16,565.00
Mar 31, 2024 16,565.00
Dec 31, 2023 38,044.00
Dec 31, 2023 38,044.00